U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. About FDA
  3. Jobs and Training at FDA
  4. Scientific Internships, Fellowships / Trainees and Non-U.S. Citizens
  5. FDA Pharmacy Student Experiential Program
  6. DDI Webinar Series: FDA Post-Marketing Drug Safety Surveillance- March 7, 2017
  1. FDA Pharmacy Student Experiential Program

DDI Webinar Series: FDA Post-Marketing Drug Safety Surveillance- March 7, 2017

FDA’s Division of Drug Information in the Center for Drug Evaluation and Research (CDER) is excited to present a series of educational webinars targeting the needs of all healthcare professionals and students, including physicians, physician assistants, nurses, pharmacists, and pharmacy technicians. Interact with FDA staff from a variety of divisions and learn more about the FDA and drug regulation!

 
On March 7, 2017, CDER's Office of Communication, Division of Drug Information (DDI) hosted a webinar titled: FDA Post-Marketing Drug Safety Surveillance. Pharmacovigilance is defined as the science and activities relating to the detection, assessment, understanding, and prevention of adverse effects or other drug-related problems. This presentation provided an overview of pharmacovigilance and FDA’s pharmacovigilance activities.
 
 
 
Activity Outline and Continuing Education Information: FDA Post-Marketing Drug Safety Surveillance (PDF - 41KB)

If you have never attended an Adobe Connect meeting before:

Test your connection: https://collaboration.fda.gov/common/help/en/support/meeting_test.htm

Get a quick overview: http://www.adobe.com/go/connectpro_overview 

Adobe, the Adobe logo, Acrobat and Adobe Connect are either registered trademarks or trademarks of Adobe Systems Incorporated in the United States and/or other countries.

ResourcesForYou

Back to Top